Abstract: Herein is described an ocular composition comprising an ocular decongestant such as phenylephrine and certain labdane derivatives which are intraocular pressure lowering agents. The composition not only markedly reduces the ocular reddening otherwise produced by such labdane compounds, but also unexpectedly prolongs and frequently potentiates their intraocular pressure lowering effect. Both of these effects are very beneficial to the use of such labdanes for the treatment of glaucoma.

Abstract: Clearance of antibody-coated cells from the circulation of mammals is inhibited by administering an effective amount of 17-hydroxyprogesterone or 16-methylprogesterone. The compounds are useful in treating autoimmune disease.

Abstract: Diphenylamine which is unsubstituted or substituted by alkyl or alkoxy groups can be prepared by treating appropriately substituted dicyclohexylamine with 1-10 bar of H.sub.2 over catalysts containing 0.05-5% by weight of rhodium at 250.degree.-450.degree. C. In addition to rhodium, the catalysts contain at least one other platinum metal from the group consisting of palladium, platinum and iridium on a support containing the noble metals in a total amount of 0.05-5% by weight, the percentage by weight of rodium with respect to all noble metals being 10-90%, and furthermore containing additives of 1-6% by weight of an alkali metal hydroxide and 1-6% by weight of an alkali metal sulphate. All percentages are based on the total weight of the catalyst.

Abstract: A process for converting in depth a carbon or graphite preform object to a silicon carbide object, silicon carbide/silicon object, silicon carbide/carbon-core object, or a silicon carbide/silicon/carbon-core object, by contacting it with silicon liquid and vapor over various lengths of contact time in a reaction chamber. In the process, a stream comprised of a silicon-containing precursor material in gaseous phase below the decomposition temperature of said gas and a coreactant, carrier or diluent gas such as hydrogen is passed through a hole within a high emissivity, thin, insulating septum into the reaction chamber above the melting point of silicon. The thin septum has one face below the decomposition temperature of the gas and an opposite face exposed to the reaction chamber. Thus, the precursor gas is decomposed directly to silicon in the reaction chamber. Any stream of decomposition gas and any unreacted precursor gas from the reaction chamber is removed.

Abstract: A zootechnical association comprising (a) a zootechnical composition containing a beta adrenergic and (b) a zootechnical composition containing a steroid of the formula ##STR1## wherein X is selected from the group consisting of hydrogen, optionally unsaturated alkyl of 1 to 6 carbon atoms wherein one of the carbon atoms may be replaced by --O-- and acyl of an organic carboxylic acid of 1 to 18 carbon atoms and a method increasing the weight and quality of meat of animals by administration simultaneously, separately or spread out over a period of time.

Abstract: A pharmaceutical composition is provided for oral administration. The composition comprises estradiol dissolved in an oil vehicle containing a suspension of micronized progesterone. The oil vehicle is high in glycerides of polyunsaturated fatty acids. The estradiol and micronized progesterone contained in the oil are more readily absorbable in the blood stream and achieve enhanced estradiol and progesterone blood serum levels. The pharmaceutical composition according to the invention can be readily formulated into capsules and administered for the treatment of menopausal symptoms.

Abstract: A novel medicine containing isoliquiritigenin as the active ingredient is disclosed, which exhibits excellent effects when used as a medicine for the therapy and prevention of kidney diseases, a medicine for the therapy and prevention of liver diseases, and a medicine for the therapy and prevention of complication resulting from diseases of these organs.

Abstract: Compounds of the formulae: ##STR1## are useful as anti-cancer, anti-obesity, anti-diabetic, anti-coronary agents, anti-aging agents, anti-hypolipidemic agents and anti-autoimmune agents.

Abstract: The present invention provides novel compounds for controlling mammalian obesity by simultaneous action upon caloric intake and caloric expenditure. This is accomplished by the administration of pharmaceutically acceptable and therapeutically active analogs of .alpha.-HET and .beta.-HET, having a methyl group at the 3.beta. position to avoid metabolically induced conjugation of the molecule to an inactive species while retaining the structural integrity of the molecule.

Abstract: Novel antitussive and anesthesic liquid compositions of matter for oral use comprising an effective oral antitussive drug and phenol, and method of using same.

Abstract: A process for producing a steroid compound which is useful as an intermediate for synthesizing plant growth regulators, brassinosteroids, and is represented by the general formula (4): ##STR1## in which R.sub.2 is a methyl or ethyl, and * indicates the binding site of R.sub.1 to a steroid nucleus, or general formula (5): ##STR2## wherein R.sub.1 is as defined above. According to the process disclosed herein, an intermediate for a brassinolide, epibrassinolide, homobrassinolide or derivatives thereof can be produced highly advantageously in the industries.

Abstract: An integrated process is disclosed for the conversion of C.sub.2 + normal olefins into methyl tertiaryalkyl ethers and high octane gasoline. The process combines olefins interconversion with etherification and conversion of unreacted methanol and olefins in contact with acidic, shape selective metallosilicate zeolite catalyst.

Abstract: Hydrotreating catalyst composition comprising a hydrogenating component consisting essentially of a metal component in which the metal is selected from Group VIB and a phosphorus component, deposed on the surface of a support comprising a porous refractory inorganic oxide and free of zeolite component exhibits excellent hydrotreating activity and lifetime, particularly in the hydrodenitrogenation of high nitrogen feeds, e.g., whole shale oils or fractions thereof, and in the hydrodesulfurization and hydrodemetallation of high sulfur feeds, e.g., vacuum or atmospheric residual.

Abstract: New chiral catalysts for asymmetric synthesis reactions. The catalysts induce chirality in desired fashion in product molecules. The catalysts are rigid quadruped or triped ligands which provide a rigid asymmetric enantio-face at the active catalyst cite, thus inducing preparation of enantiomer molecules.

Abstract: A process for the production of alkylaromatic hydrocarbons uses a light hydrocarbon recycle to reduce the costs of separating an unreacted aromatic feed substrate from aromatic hydrocarbon products. Unreacted aromatic substrate is combined with a light hydrocarbon, such as propane, to form a combined effluent stream. The combined effluent stream enters a flash separator where unreacted aromatic substrate is lifted overhead with the light hydrocarbon while heavier aromatic products are recovered below. The aromatic substrate and light hydrocarbon are easily separated in a simple separation zone. Lifting the aromatic substrate with the light hydrocarbon reduces the volume of aromatic substrate that remains with the aromatic product so that the more energy intensive separation of the aromatic substrate and aromatic product is performed on a reduced volume of material.

Abstract: Method for crystallization of a water and honey mixture by means of lyophilizing apparatus, having a honey-water mixture container, including the steps of preparing the mixture of honey and water; placing the mixture in the container; vibrating it in the container until the mixture is homogeneous; lyophilizing the homogeneous mixture of honey and water and finally removing the freeze-dried honey from the container.

Abstract: Disclosed herein is an immunoregulator comprising a derivative of estradiol represented by the formula (I), which immunoregulator has a small influence to the non-specific immunoreactions in general and gives a specific influence to the immunoreactions against an isoantibody.

Abstract: Reticulocytes, RNA or DNA are stained with a dye for detection in a flow cytometer. The dye has the formula: ##STR1## Wherein: X=O,S, Se, N -alkyl (having 1-6 carbons) or C (CH.sub.3).sub.n ; R.sub.1 =alkyl having from 1-6 carbons;R.sub.2 =alkyl having from 1-6 carbons;R.sub.3 =fused benzene, alkyl (having 1-6 carbons), methoxy or is absent;R.sub.4 =alkyl having 1-6 carbons, methoxy or is absent; andn=zero or an integer from 1-6.